NOVELTY – Topical formulation comprises 0.1-15% dry extract of leaves of Maytenus ificifolia (MI) selected from MI40, MI60 or MI80 extract and comprises 85.0-130.0 mg/g catechin, 171.0-221.0 mg/g epicatechin and 29.0-56.0 mg/g rutin extract, 0-0.5% Carbopol (RTM: Rheology modifier), 0-8% Cosmowax (RTM: Versatile nonionic surface active agent), 4% mineral oil, 0.05% butylated hydroxytoluene, 0.10% ethylenediaminetetraacetic acid, 0.18% methylparaben, 0.02% propylparaben, 10% glycerine, 6% propylene glycol, sodium hydroxide having pH of 6.0-6.5 and 100% water. USE – Topical formulation used for external treatment of skin and hair (claimed). ADVANTAGE – The topical formulation has antioxidant and anti-inflammatory activity.
B04 (Natural products and polymers. Including testing of body fluids (other than blood typing or cell counting), pharmaceuticals or veterinary compounds of unknown structure, testing of microorganisms for pathogenicity, testing of chemicals for mutagenicity or human toxicity and fermentative production of DNA or RNA. General compositions.); D21 (Preparations for dental or toilet purposes – including filling alloys, compositions for dentures or dental impressions, anti-caries chewing gum, plaque disclosing compositions, toothpastes, cosmetics, shampoos, topical anti-sunburn compositions and toilet soaps (A61K).); B02 (Fused ring heterocyclics.)